ALK-positive lung cancer

Clinical trials for ALK-positive lung cancer explained in plain language.

Never miss a new study

Get alerted when new ALK-positive lung cancer trials appear

Sign up with your email to follow new studies for ALK-positive lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New pill shows promise against tough lung cancer

Disease control Recruiting now

This study tests a new daily pill called TRI-611 for adults with advanced ALK-positive non-small cell lung cancer (NSCLC) that has not responded to other treatments. The trial has two parts: first, finding the safest dose, and second, seeing how well it shrinks tumors in differen…

Matched conditions: ALK-POSITIVE LUNG CANCER

Phase 1/2 • Sponsor: TRIANA Biomedicines, Inc. • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC

ALK-positive lung cancer

Get alerted when new ALK-positive lung cancer trials appear

New pill shows promise against tough lung cancer